Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Mammary Gland Biology and Neoplasia
Appendix
Available only for authorised users
Metadata
Title
RETRACTED ARTICLE: Inhibition of Tumor Progression by NG-Nitro-L-arginine Methyl Ester in 7,12- dimethylbenz(a)anthracene Induced Breast Cancer: Nitric Oxide Synthase Inhibition as an Antitumor Prevention
Authors
Nikolay Avtandilyan
Hayarpi Javrushyan
Anna Karapetyan
Armen Trchounian
Publication date
01-06-2019
Publisher
Springer US
Keyword
Nitroglycerin
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 2/2019
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-019-09428-0

Other articles of this Issue 2/2019

Journal of Mammary Gland Biology and Neoplasia 2/2019 Go to the issue

ReviewPaper

A Comparative Review of Mixed Mammary Tumors in Mammals

OriginalPaper

A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

OriginalPaper

A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue

OriginalPaper

Mammary Epithelial Cell Lineage Changes During Cow’s Life

ReviewPaper

Metformin and Breast Cancer: Molecular Targets

ReviewPaper

Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits